Adeline Hui Ling Lau

Title: Adeline Hui Ling Lau: Innovator in Cell Line Development

Introduction

Adeline Hui Ling Lau is a prominent inventor based in Singapore, known for her significant contributions to the field of biotechnology. She has developed innovative solutions that address critical challenges in the swine industry, particularly concerning porcine circovirus type 2 (PCV2).

Latest Patents

Adeline holds a patent for the "Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection." This invention describes continuous cell lines that are highly permissive to infection by PCV2, which is the causal agent of post-weaning multi-systemic wasting syndrome (PMWS) in pigs. PMWS has emerged as a major disease that poses a significant threat to the economics of the global swine industry. The highly permissive cell lines of this invention provide efficient and reliable sources of PCV2 for use in the development of vaccines, therapies, and diagnostic agents for PMWS. She has 1 patent to her name.

Career Highlights

Adeline is associated with Temasek Life Sciences Laboratory Limited, where she has been instrumental in advancing research in cell line development. Her work has garnered attention for its potential impact on the swine industry and animal health.

Collaborations

Adeline has collaborated with notable colleagues, including Jennifer Siew Kee Lau and Hwei-Sing Jimmy Kwang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Adeline Hui Ling Lau's work exemplifies the intersection of innovation and practical application in biotechnology. Her contributions are vital for addressing significant challenges in the swine industry, showcasing her role as a leading inventor in this field.